Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Auditor change
Credit agrmnt [a]
Director departure
Employment agrmnt
HORIZON PHARMACEUTICAL LLC (RPTP) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/20/2019 CT ORDER Form CT ORDER - Confidential treatment order:
02/01/2018 CT ORDER Form CT ORDER - Confidential treatment order:
02/21/2017 SC 13G/A Credit Suisse Trust Ltd reports a 0% stake in Horizon Pharmaceutical LLC
02/14/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/13/2017 SC 13G/A Credit Suisse Trust Ltd reports a 5.1% stake in Raptor Pharmaceutical Corporation
11/04/2016 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
10/31/2016 8-K Quarterly results
10/31/2016 EFFECT Form EFFECT - Notice of Effectiveness
10/31/2016 EFFECT Form EFFECT - Notice of Effectiveness
10/31/2016 EFFECT Form EFFECT - Notice of Effectiveness
10/31/2016 EFFECT Form EFFECT - Notice of Effectiveness
10/31/2016 EFFECT Form EFFECT - Notice of Effectiveness
10/26/2016 4 Bruhn Suzanne Louise (Director) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 GEMAYEL GEORGES (Director) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 Happel David (Chief Commercial Officer) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 Smith Michael P (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 Gould Ashley C. (Chief Legal Officer) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 Smith Julie (President and CEO) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 Keltner Llew (Director) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 FRANKLIN RICHARD L (Director) has filed a Form 4 on Raptor Pharmaceutical Corp
Txns: Unknown transaction of 6,695 shares @ $9, valued at $60.3k
Disposed/sold 8,330 shares @ $9, valued at $75k
Disposed/sold 90,000 options to buy @ $3.54, valued at $318.6k
Disposed/sold 120,000 options to buy @ $5.13, valued at $615.6k
Disposed/sold 50,000 options to buy @ $5.49, valued at $274.5k
10/26/2016 4 STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp
10/26/2016 4 Polu Krishna R (Chief Medical Officer) has filed a Form 4 on Raptor Pharmaceutical Corp
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy